IMROZ- IsaRVd vs RVd in Newly Diagnosed Transplant Ineligible MM | Thierry Facon, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 5:06 2 months ago 109 Далее Скачать
Algorithm for elderly patients | Thierry Facon Tetsuzan Benny Ron 22:44 7 years ago 133 Далее Скачать
Doing More with Less - Thierry Facon Daugherty Water for Food Global Institute 23:08 10 years ago 228 Далее Скачать
Thierry Facon: D-Rd vs. Rd in NDMM Ineligible for Transplant (MAIA) Oncoletter 6:11 5 years ago 463 Далее Скачать
Thierry Facon, Centre Hospitalier Régional Universitaire de Lille, Lille, France Oncoletter 8:30 10 years ago 962 Далее Скачать
פרופ' טיארי פקון - Prof. Thierry Facon Amen Israel -עמותת אמן - מיאלומה נפוצה 14:37 12 years ago 192 Далее Скачать
Dr Facon on the Implications of Isatuximab Plus VRd in Transplant-Ineligible Newly Diagnosed Myeloma OncLive 0:53 1 month ago 21 Далее Скачать
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:54 9 years ago 296 Далее Скачать
Daratunumab found to increase PFS in patients with transplant-ineligible newly diagnosed multipl... ecancer 5:35 5 years ago 17 Далее Скачать
IMROZ: Isa-VRd vs VRd for transplant-ineligible newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:57 2 months ago 75 Далее Скачать
IACH 2019 Live - Management of elderly myeloma 30 years of active research International Academy for Clinical Hematology IACH 19:30 5 years ago 680 Далее Скачать
Debate - Continuous therapy as a standard of care | Facon Tetsuzan Benny Ron 16:25 6 years ago 85 Далее Скачать
Monoclonal antibodies for the treatment of multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:34 9 years ago 152 Далее Скачать
